Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dyna-Hex 2% Antiseptic Skin Cleanser is an over-the-counter (OTC) topical antiseptic solution developed by Xttrium Laboratories. Formulated with 2% chlorhexidine gluconate (CHG), a cationic bisbiguanide, it is indicated for surgical hand scrubbing, healthcare personnel handwashing, patient preoperative skin preparation, and skin wound and general skin cleansing. Chlorhexidine gluconate exerts its rapid and persistent antimicrobial activity by electrostatically binding to the negatively charged bacterial cell wall and cell membrane, leading to membrane disruption, leakage of intracellular components, and subsequent cell lysis. Dyna-Hex 2% provides broad-spectrum efficacy against Gram-positive and Gram-negative bacteria, as well as fungi and yeasts, with persistent antimicrobial action lasting up to six hours.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chlorhexidine gluconate 2% solution.